Levera XR 500 Tablet
By Levera
Rx
10 Tablet PR in a Strip

Composition
Levetiracetam(500mg)

Manufacturer - Intas Pharmaceuticals Ltd
Chinubhai Centre, Off. Nehru Bridge, Ashram Road, Ahmedabad - 380009. Gujarat. India.

Expires on or after
March, 2026

liver
Levera XR 500 Tablet appears to be generally safe for use in patients with liver disease, as indicated by the limited available data. It is recommended to consult with your doctor regarding its usage. In cases of severe liver disease, a lower dose may be recommended to ensure safety and effectiveness. Additionally, Levesam 500 Tablet 15's should be used with caution in individuals with a history of liver disease, and dosage adjustments may be necessary under the guidance of a healthcare provider. It is always advisable to seek professional medical advice before initiating treatment with Levera XR 500 Tablet in such scenarios.

kidney
Levera XR 500 Tablet requires caution for individuals with kidney disease. Dosage adjustment may be necessary, and consulting a doctor is advised. Levesam 500 Tablet 15's should also be used cautiously for those with a history of kidney disorders, with dose adjustments as per doctor's recommendation. Avoid giving Levesam 500 Tablet 15's to dialysis and kidney failure patients.

alcohol
It is advised to avoid drinking alcohol with Levera XR 500 Tablet to prevent side effects like drowsiness, dizziness, and sleepiness. Combining alcohol with this medication can also be dangerous and may lead to a life-threatening coma.

driving
When taking Levera XR 500 Tablet, be cautious as it may lessen alertness, impact vision, and induce drowsiness or dizziness. Avoid driving if experiencing these symptoms to ensure safety. Inform your doctor of any related side effects.

pregnancy
Levera XR 500 Tablet is safe to use during pregnancy; studies suggest low to no risk to the baby. It is advisable to consult your doctor before using Levera XR 500 Tablet.

breastfeeding
Levera XR 500 Tablet may be safe for breastfeeding as limited data shows no significant risk to the baby. Monitor baby for sleepiness and weight gain. Inform your doctor if planning to breastfeed while on this medication.
Habit Forming | No |
Chemical Class | Pyrrolidinone & Acetamide Derivative |
Therapeutic Class | NEURO CNS |
Action Class | Synaptic vescicle 2 A protein ligand (AED) |
₹145.38
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024